Nursing and Health Professions
Prevalence
36%
Metabolic Syndrome X
35%
Parkinson's Disease
35%
Male
32%
Hospital
31%
Hemodialysis
31%
Patient
30%
Physician
29%
Female
25%
Hospitalization
22%
Incidence
20%
Body Mass
20%
Confidence Interval
19%
Death
17%
Spine Fracture
17%
Hip Fracture
17%
Older People
17%
Cohort Analysis
17%
Liver Enzyme
17%
Socioeconomic Status
16%
Child
14%
Odds Ratio
14%
Parkinson Disease
14%
Logistic Regression Analysis
13%
Health Inequality
13%
Underweight
12%
Mortality
12%
All Cause Mortality
11%
Density
11%
Clinical Management
11%
Survival
11%
Infection
11%
Comorbidity
10%
Fracture
10%
Obesity
10%
Medication Compliance
8%
Hazard Ratio
8%
Diabetes Mellitus
8%
Non Insulin Dependent Diabetes Mellitus
8%
Oral Antidiabetic Agent
8%
Nurse Specialist
8%
End Stage Renal Disease
8%
Resource Allocation
7%
Heart Failure
7%
Medication Therapy Management
7%
Nurse Attitude
7%
Cerebrovascular Accident
5%
Variance
5%
Chronic Kidney Failure
5%
Kaplan Meier Method
5%
Medicine and Dentistry
Patient
100%
Percutaneous Coronary Intervention
33%
Hemodialysis
31%
Hospital
28%
Association
20%
Long-Term Care
19%
Health Care Cost
19%
Medical Care
19%
All Cause Mortality
18%
Smoking
17%
Hazard Ratio
17%
Prevalence
16%
Older Adult
15%
Bullous Pemphigoid
15%
Mortality
15%
Parkinson's Disease
14%
Therapeutic Procedure
13%
Apoplexy
12%
Inpatient
12%
Survival
11%
Dipeptidyl Peptidase-4 Inhibitor
11%
Cost Sharing
10%
Health
10%
Retrospective Cohort Study
8%
Proportional Hazards Model
8%
Infection
8%
Follow up
8%
Cancer
8%
End Stage Renal Disease
8%
Health Outcomes
8%
Sitagliptin
7%
Vildagliptin
7%
Linagliptin
7%
Female
7%
Age
7%
Health Care
7%
Heart Failure
7%
Acute Heart Infarction
7%
Revascularization
7%
Death
6%
Gender
5%
Disparity
5%
Senescence
5%
Chronic Kidney Disease
5%
Development
5%
Health Inequality
5%
Physician
5%
Pharmacology, Toxicology and Pharmaceutical Science
Metabolic Syndrome X
35%
Prevalence
21%
Incidence
20%
Hemodialysis
19%
Pancreas Cancer
17%
Streptococcus Infection
17%
Smoke
17%
Depression
17%
Hypnotic
17%
Parkinson Disease
17%
Injury
17%
Liver Enzyme
17%
Bullous Pemphigoid
15%
Cohort Study
15%
Benzodiazepine
12%
Infection
11%
Pharmacotherapy
10%
Second-Line Chemotherapy
10%
Femur Fracture
10%
Survival
9%
Tobacco Dependence
8%
End Stage Renal Disease
8%
Alogliptin
7%
Melatonin Receptor Agonist
7%
First-Line Chemotherapy
7%
Gemcitabine
7%
Chronic Kidney Failure
5%
Confounder
5%
Mortality
5%
Fracture
5%
Nonbenzodiazepine
5%
Obesity
5%
